We have constructed a multimodal contrast agent suitable for near-infrared, NIR, fluorescent imaging as well as magnetic resonance imaging, MRI. This class of agents may be useful for preoperative tumor localization and tumor functional evaluation and for intraoperative delineation of tumor margins. We have covalently attached dyes of the cyanine family to a previously described polymeric contrast agent, Gd-DTPA-polylysine, of an extended, uncoiled conformation. The dual modality agent is as effective in imaging tumors by MRI as the parent compound provided that the dye loading on the polymer is such that it does not eliminate all the available free-lysine groups on the parent Gd-DTPA-polylysine polymers. NIR fluorescence from preclinical subcutaneous and orthotopic mammary gland tumors could be detected with a signal to background ratio of as high as 4.5 at 12 hours post agent injection at a dye dose of 125 nmole/kg. For intraoperative delineation of tumor margins, a wide-field illumination camera system was devised giving high signal to background NIR fluorescent images of surgically exposed orthotopic mammary gland tumors. Histologic microscopy confirmed the location of the dual modality agent at the boundary of the tumor with a margin distance of about 0.3 mm from labeled tumor cells.
Introduction
The delineation of tumor margins in tumor resection is an important clinical need. Imaging methods that will allow a better delineation of tumor margins intra-operatively would diminish the probability of local tumor recurrence in a sizable fraction of tumor resection procedures (1-3). The targeting of optical agents to tumors is one obvious approach to this problem that could be readily adapted to surgical instrumental demands (4) . Although some fluorescent agents exist for such a purpose -the dye labeled peptide, RGD-cy5.5, binding to α v β 3 integrins on U87MG glioma cells, (5), the tumor to background may not be adequate for tumors with only moderate α v β 3 integrin upregulation and it is, therefore, not clear whether this vector is sufficiently general. An alternative strategy for addressing this problem is through the use of a polymeric multimodal agent of applicability to most solid tumors and that may be also used for preoperative tumor localization and functional characterization.
We postulated that an existing polymeric MRI agent, Gd-DTPA-polylysine, which accumulates in tumors through the leaky angiogenic vasculature of tumors (6-7) may serve as a starting point for this problem. Optical dyes can be readily attached to polymeric Gd-DTPA-polylysine as the conjugation of DTPA to Technology in Cancer Research & Treatment, Volume 5, Number 4, August 2006 polylysine is never at 100%, and there are free lysine groups available for the linking chemistry (7) . This approach would yield a dual modality agent in which MRI images could be taken for detailed preoperative localization and characterization of tumor lesions and the fluorescence signals could be used intra-operatively to guide tumor resection by delineating angiogentic vessel development. Proof of concept of a dual agent approach was demonstrated in a preclinical glioma model using iron oxide particles conjugated with Cy5.5 dyes (8) . Tumor margins were well defined by the fluorescent particles 24 hours post injection. The particles were taken up by macrophages and microglial cells associated with the tumor but not by the tumor cells directly. We wish to test this mutlimodal approach with a different tumor localization method of a broad generality and with a positive T 1 weighted signal enhancement capability for MRI imaging.
A second motivation for developing such dual modality agents is to test the possibility that optical methods either through surface fluorescence or diffuse optical tomography, DOT, could yield comparable kinetic agent tumor uptake signals as found with macromolecular MRI agents. Macromolecular contrast agents in MRI have been used widely in pre-clinical studies. They have been very effective in determining two hemodynamic parameters that correlate strongly with tumor grade: tumor blood volume and tumor permeability (9). Thus determining either of these parameters may be a useful indicator for tumor prognosis (9-11) and tumor response to therapy (12) (13) (14) . To validate dynamic optical contrast signals, the dual modality agent could be used both in MRI and in optical systems on the same tumors, or ideally in sequential measurements in a combined MRI/DOT imaging system.
Materials and Methods

General Methods
Polylysine, diethylenetriaminepentaacetic acid (>99%), isobutylchloroformate (>99%), triethylamine (>99%), gadolinium chloride, trisodium citrate, and trinitrobenzene sulfonic acid (TNBSA, Pierce) were used as received; acetonitrile was distilled over CaH 2 ; 18Ω water was obtained from a Millipore four-stage filtration device. All reactions were performed on a Schlenk line under an N 2 inert atmosphere unless otherwise stated using glassware that had been prerinsed with 18 MΩ water. Prior to use for material purification, 5kDa and 10kDa MWCO ultrafilters (Amicon) were pre-rinsed with 18 MΩ water at 4000 rpm on a centrifuge (Sorvall RC-5B Superspeed Centrifuge, equipped with swinging bucket rotor). HPLC analysis was performed using a Dionex LC25 chromatography oven fitted with an Agilent Zorbax GF250 column, an AD25 absorbance detector, and a GP40 gradient pump eluting with a potassium phosphate buffer (pH 7, 20mM, 165mM NaCl) .
Synthesis
Synthesis of DTPA-PL:
A previous synthesis protocol for DTPA coupling to polylysine, PL (7, 15), a mixed anhydride of DTPA reaction to the amino group of lysine, was modified in several important ways to allow for achievement of high DTPA conjugation, ~95% range, with high yield and purity (i.e., reduction of intramolecular bonding through divalent anhydride species in the reaction).
A sample of DTPA (3.38 g, 8.7 mmol) and acetonitrile (46 mL) was degassed for 20 minutes. Upon addition of NEt3 (6.20 ml, 43.9 mmol), the reaction mixture was heated to 60 ºC for one hour with stirring. The resultant clear, colorless solution was then transferred by syringe to a three-necked flask, equipped with a mechanical stirrer, and cooled to -40 ºC. An acetonitrile solution (23 mL) of i-BuCOCl (1.25 mL, 9.7 mmol) was then added to the reaction mixture at a rate of 1.2 ml·min -1 over the course of 20 minutes. The reaction mixture was allowed to stir for one hour at -45 ºC, resulting in the gradual formation of a white precipitate, at which point stirring was halted.
Under an inert atmosphere, one neck of the reactor was equipped with a septum fitted with a Teflon tube that was inserted into the reaction mixture. The DTPA reagent was maintained at -40 ºC, and then pumped (4.4 ml·min -1 for 17 minutes) to a second reactor containing a clear, colorless aqueous NaHCO 3 (0.1 M, pH 10)/NaCl (2 M, 2.69 g, 46 mmol) solution (23 mL) of polylysine (0.25 g, 1.2 mmol M w = 84,000 g·mol -1 , degree of polymerization, DP = 402) at ambient temperature. The resulting cloudy biphasic reaction mixture stirred vigorously in a baffled reactor for 16 hours, at which point stirring was stopped, the reaction mixture transferred to a separatory funnel and then allowed to settle into two clear colorless phases. The lower aqueous layer was separated and added to an aqueous NaHCO 3 (0.1 M, pH 10)/ NaCl (2 M, 2.69 g, 46 mmol) solution (23 mL) to afford a clear colorless solution of the crude product.
The resultant crude reaction mixture was purified by ultrafiltration (4x Amicon Ultrafilters, 10K MWCO, 2000 rpm), and washed with five cycles of distilled water (4 × 12mL, 18MΩ) to remove low MW byproducts, as verified by GPC, providing the product Poly(lysine-DTPA) as a clear colorless DI solution, in an 84% yield, with a 98% purity (HPLC) and 97±1.4% conjugation, MW using Multiangle Laser Light Scattering ("MALLS") = 208kDa.
Synthesis of Gd-DTPA-PL: Direct Gadolinium Labeling of Poly(lysine-DTPA) in the Synthesis of Poly(lysine-DTPA-Gd).
The crude PL-DTPA product described above was treated with GdCitrate (44 mL, 0.3 M) and allowed to stir at ambient temperature for 16 hours. The crude reaction mixture was then concentrated to 40 mL volume by ultrafiltration (4x Amicon Ultrafilters, 10K MWCO, 2000 rpm), and washed with five cycles of distilled water (4 × 12 mL, 18MΩ) to remove low molecular weight by-products, as verified by GPC, providing the product Poly(lysine-DTPA-Gd) as a clear colorless DI solution, in a 71% overall yield, with 99% purity (GPC) and 97±1.4% conjugation, MW (MALLS) = 270 kDa.
Conformation of Gd-DTPA-PLL products was further evaluated by HPLC relative to globular protein standards using a TSK-GEL G-DNA-PW(Tosho Biosep, Montgomeryville, PA) gel permeation column. The elution times of protein molecular weight standards (ranging in M w from 29kDa to 669kDa) and the various polymer products were compared as a function of amino acid residue number. The elution buffer was 50mM Na 2 HPO 4 and 200mM NaCl at pH 7 at a flow rate of 0.6 ml/min. A linear elution time profile was observed for the protein standards as a function of log M w or log N, where N is the number of amino acids.
Synthesis of dye-Gd-DTPA-PL:
In these examples the following reagents were used: the Cy5, Cy5.5, Cy 7, NHS esters (GE Healthcare); IR800 NHS ester (LiCOR); all other materials were obtained from Aldrich.
Conjugating the dye to the polymer. Gd-DTPA polylysine (~4-6 μmol free lysines) was dissolved in 0.4 ml of 0.1 M sodium carbonate at pH 8.6-8.8 (adjusted by addition of sodium carbonate). NHS ester of dye was dissolved in DMSO (1 mg/30 μl) and a portion of this solution containing 0.05 μmol of active dye-NHS ester/μmol of free lysine (calculated based on % chromophore and % NHS ester information provided by the supplier) was added to the Gd-DTPA polylysine solution.
The mixture was vortexed and stored at room temperature overnight in the dark with occasional vortexing. The mixture was then diluted with water to reduce the percentage of DMSO to less than 5% and then filtered on an Amicon filter (MW cutoff 10,000) at 4 ºC. The residue was washed repeatedly with water (10-15 ml) until the filtrate was almost colorless (at least three washes). The residual material was purified on Superdex 200, 10 × 300 mm column using water as eluant at a flow rate of 0.5 ml/minute.
The product was collected in fractions, which were pooled into a smaller number of fractions based on elution profile. These fractions were analyzed by: UV for dye concentration; HPLC for presence or absence of low molecular weight impurities; and ICP-MS for Gd analysis. HPLC analyses were performed on Agilent Zorbax GF-250, 4.6 × 250 mm column, particle size 4 μm optical imaging applications using 1X PBS as elution buffer at 0.5 ml/min, as well as on Tosoh Biosciences G-DNA-PW 7.8 × 300 mm column, particle size 10 μm using 200mM NaCl at 0.5 ml/min. Dye loading was calculated using UV absorbance and Gd analysis of the synthesized constructs.
Synthesis of Gd-DTPA-PLL-Cy dye with medium or high dye loading. Gd-DTPA polylysine (~3 μmol free lysines) was dissolved in 0.4 ml of 0.1 M sodium carbonate at pH 8.6-8.8 (adjusted by addition of sodium carbonate). NHS ester of dye was dissolved in DMSO (1 mg/30 μl) and a portion of this solution containing 0.6-1.2 μmol (0.6 for medium and 1.2 for high) of active dye-NHS ester/μmol of free lysine (calculated based on % chromophore and % NHS ester information provided by the supplier) was added to the Gd-DTPA polylysine solution. The product was purified and fractionated as described above.
Animal Model
Rat mammary adenocarcinoma cells, (Mat B, ATCC 13762), were implanted either subcutaneously or orthotopically in the mammary gland of female Fisher 344 rats. Subcutaneous tumors were grown by implanting 2 × 10 6 cells in 0.2ml Hank's balanced salt solution beneath the dorsal skin flap while animal was anesthetized. After about eight days the tumors reached a size of between 5 to 10 mm in diameter. Orthotopic implantation was done as follows. Intra-mammary gland tumor injection is a survival surgery. All procedures are performed with the animal lying on a circulating water pad. With the anesthetized rat lying on its back, the sterile prepped ventral abdominal skin is picked up, just above the left groin (inguinal) area and a small incision is made with scissors being careful to avoid the underlying peritonium. The fourth mammary gland is easily visible, lying on the dorsal surface of the skin directly on top of a junction point for the mammary artery and vein. Using a 1cc syringe, 10 6 cells (0.1ml) were injected directly into the gland. Only one mammary gland per rat was inoculated with tumor cells. The skin wound was closed with surgical staples. Surgical staples were removed three days after insertion. Tumors grew to about 5-10 mm diameter in eight days, whereupon imaging studies commenced.
Magnetic Resonance Imaging
MR imaging was done on a 1.5T GE Signa scanner using a solenoid receive coil built for small animal imaging -5 cm diameter by 10 cm. A T 1 weighted spin echo sequence was used (TE = 9 ms, TR = 250 ms, 12 × 12 cm FOV, 1 mm slice thickness, 2NEX). For dynamic contrast enhancement, an image was obtained prior to agent injection and immediately after injection and every four minutes thereafter for up to 30 minutes. Late phase imaging was done at 24 hours post injection.
Animals were anesthetized with a intraperitoneal injection of a mixture of acepromazine, xyalzine, ketamine, and atropine Technology in Cancer Research & Treatment, Volume 5, Number 4, August 2006 and placed in the receive coil for imaging. The agent was injected by tail vein at 0.025 mmole Gd/kg, which corresponds to 65 nmole polymer/kg.
To assay tumor permeability, ROI regions encompassing the entire tumor were taken for three to four image slices of the tumor. A signal enhancement curve was generated for each image slice as a function of time using a histogram method for the signal change values for each pixel. Since the tumor permeability responses were heterogeneous spatially, we used the highest 10% of the responding image pixels to define the high 10% value of tumor permeability. This approach gave lower variance of permeability values from animal to animal then the use of the entire tumor average permeability, which entails sizable variations due to development of nonresponding necrotic regions in tumors that reach 10 mm sizes.
Late phase images at 24 hours gave tumor enhancement that was highest at the rim of the tumors giving a bright continuous delineation of the tumor rim. These late phase responses were also the ones giving the highest tumor to background signals with the intraoperative camera system.
Intraoperative NIR Camera System
A near-infrared fluorescence imaging system was used to acquire the surgical images. The system was similar to one used in Dr. John Frangioni's laboratory at Beth Israel Deaconess Medical Center in Boston (4) . Fluorescence images were captured by a NIR-sensitive cooled Hamamatsu Orca-ER camera while visible color images were captured by an Imitec EPS-080CF camera. The cameras were mounted in a device (Thales-Optem) to align the cameras on the surgical field and provide focus and zoom. Several ultra high power illuminators, LEDs from Epitex Inc, supplied excitation light to the surgical field. Filters (Chroma Technology Corp.) were used to bandpass the excitation light and longpass the emission light to the NIR camera. A dichroic mirror (Chroma Technology Corp.) reflected the visible image to the color camera.
The software for the operating system and image acquisition was written in LabVIEW, National Instruments' graphical programming language and run on a Dell Optiplex computer. The software acquired images from both cameras and combined the images together to allow the surgeon to localize the area of fluorescence, and see three images in real-time in the operating room: visible, NIR, and merged. The software allows the user to change the exposure time, gain, and display settings. Images are stored as PNG files that can be opened and viewed in most image viewing tools.
Surgical tumor resection is a non-survival surgery. Tumors were resected when they reached a diameter in the range of 5-10 mm. With the anesthetized rat lying on its back, the ventral abdominal skin is picked up, just above the left groin (inguinal) area and a small incision is made (at or near the site of tumor inoculation) with scissors being careful to avoid the underlying peritonium. The tumor, growing in the mammary gland, stays contained in this tissue and is easily removed. The tumor was held with a pair of forceps and using a scalpel is removed from the surrounding connective tissue. After the tumor was removed, a midline incision, through the peritoneum was made, other organs were observed and imaged, and sampled for histological and biodistribution studies.
Histological Evaluation
Tumor tissue sections (10-micron thickness) were cut using a cryotome. Immunohistochemistry was performed using a mouse monoclonal PCNA antibody (Sigma) as follows: slides were washed in PBS, blocked with normal donkey serum, labeled with primary antibody (1:1000), and then in mouse anti donkey secondary (1:200). Cover slips were mounted using AntiFade Gold + Dapi (Molecular Probes). DAPI stains for nuclei in the tissue samples and PCNA stains against the proliferating cell nuclear antigen, which is a marker for tumorogenic cells. Fluorescent images with Cy5-PL, DAPI, and PCNA were acquired and stored for further analysis.
After the entire tissue sample was imaged, and regions of interest were documented, the tissue samples were then stained using H&E staining for correlation of the distribution of these target specific stains in comparison with the standard general staining patterns for tissue.
Results
Polymer Conformation and Tumor MRI
It is important to verify that the attachment of dye molecules does not alter the polymer conformation in any significant way. It is known that tight collapsed polymer conformations can behave differently from extended uncoiled polymers in terms of MR imaging efficacy: the extended polymers permeate the tumor endothelium to a greater extent than the coiled polymers (6, 7). In Figure 1 , is shown the elution patterns for globular proteins, for Gd-DTPA-PLL and for dye-Gd-DTPA-PLL for both low dye loading (one dye per polymer, and high dye loading, 16 dyes per polymer). The elution pattern of the dual agent constructs is consistent with an extended structure as the elution times are just below the expected position for the dye-free Gd polymers. There is no variation in retention time as a function of dye loading.
Late phase MR images are shown in Figures 2a and 2b . Although the overall conformation is not altered with high dye loading, Figure 1 ., there is a drastic reduction of tumor MR signal enhancement for the high dye content agent as can be seen in Figure 2 . This result was not expected because the conformation of the agents did not differ. The principal difference between the two cases is that in achieving the high dye content, a large excess of dye in the synthesis step ensured that all the available free lysines groups left over from the DTPA conjugation step were now linked to the dyes, leaving no positive charge groups on the polymer. That this may be the key condition for eliminating efficient trans-endothelial transport was further tested by a different lysine capping procedure in which the free lysines in Gd-DTPA-PLL were capped with trinitrobenzenesulfonic acid, TNBS (description below). In this case also, the late phase tumor enhancement was close to zero for a standard dose. In both this alteration and in the high dye case, the blood circulation levels were not significantly altered during the first hour of measurement from the dye-free agent. Therefore, this al-ternate explanation for poor late phase signal response, i.e., fast blood clearance, does not apply.
An explicit investigation in agent tumor uptake rates by, dynamic contrast enhanced MRI, DCE-MRI, was undertaken for various levels of dye loading as shown in Figure 3 .
The signal uptake slope is directly related to the agent permeability. The signal uptake slope, and therefore the permeability, does not seem to be significantly altered from zero to one dye per polymer and remains at a 150%/hr plateau until the average number of dyes reaches 16 per polymer and the signal slope drops to zero, in agreement with the late phase imaging observations. At 16 dyes per polymer there are no longer any free lysines available on the polymer construct and this fact appears to be decisive for efficient transport to occur. Blood clearance rate spanning the DCE measurement time is not effected by dye loading: At 30 minutes post injection there is no significant difference in the circulating agent blood concentration between, dyefree agent, one dye per polymer agent, and 16 dyes per polymer agent, as determined by MRI signal levels in the kidney medulla or the brain midline vein.
In an earlier set of experiments, we used another capping reaction, TNBS (trinitrobenzenesulfonic acid), to eliminate the positive charges of the unreacted, free lysines. The Gd-DTPA-PLL was reacted with 10% TNBS (2,4,6-trinitrobenzenesulfonic acid in a borate buffer, pH 9.5 for 20 minutes. The reaction was stopped with a buffer of 15mM Na 2 SO 3 in 1M NaH 2 PO 4 . The product was deep yellow with absorption maximum at 420nm. The sample was then dialyzed against 10mM NaHCO 3 and further concentration of the polymer was achieved with Amicon Centriplus concentrators (MW cutoff 3000). The TNBS capped polymers eluted at the expected time for the extended conformation on the BioSep HPLC column. The late phase signal enhancement in the tumor rim was 0% +/-10% (compared to dye-free enhancement of 100% +/-15%) and the initial uptake signal slope was also low: ~20% of the dye-free value.
Fluorescence Images
Fluorescence signals from the tumors can be readily detected with the NIR fluorescence camera system by wide field illumination of the animal as shown in Figure 4 . In the optical studies that follow, we restrict ourselves to the dual agent constructs with one dye per polymer to avoid the complication of reduced tumor signal enhancement as shown by MRI for high dye loading.
In Figure 5 is shown the optical images from a surgical tumor resection procedure. The tumor has grown into the peritoneal cavity and this invasion is clearly picked up with the NIR fluorescence.
Tumor signal to background, S/B, as function of time and two dose values are shown in Figure 6 . The dose response, at 12 hours for example, behaves as expected: The signal is linear with dose with intercept at zero when plotted as (S/B-1) vs. dose. The lack of excess signal over background at six hours indicates that background fluorescence is a factor, and signal buildup must exceed this background to mark the tumor and the tumor boundary. The high dose data at 125 nmole polymer/kg corresponds to 0.05 mmole Gd/kg, which is twice the standard MRI dose. The signal to background ratio of 4.5 at 12 hours could easily be increased by increasing the number of dyes per polymer and maintaining the same dose level of polymer (and Gd). As the previous MRI data showed for these Gd-DTPA-PLL polymers, we could go as high as 12 dye molecules per polymer without penalty of reduced transendothelial transport. However, fluorescence quenching was observed for 16 dyes per poly- mer -the emission per dye dropped to ~50% of the value found for single dye molecules.
Histology
Tumor margin in the present surgical tumor excision would be defined as the outer fluorescent delineation of the tumor and the average distance of nearest tumor cells relative to that boundary. To assess the margin, we performed histological evaluation using a stain for proliferating cells, proliferating cell nuclear antigen (PCNA) for tumor cell identification, for cell nuclei staining, DAPI, which stains cell nuclei, and NIR Cy5 channel fluorescence to localize the contrast agent position. An example, of this kind of histological evaluation is shown in Figure 7 .
The Cy5 dye agent localizes in the tumor periphery in the presence of normal mammary cells and defines the tumor boundary. The PCNA stain identifies tumor cells, which are some 0.3 mm away from the outer Cy5 boundary.
Discussion
Large molecular weight polymeric agents are useful for delineating tumor boundaries through the process of permeation through leaky angiogenic vessels. The angiogenic development of leaky microvasculature is common to all solid tumors (16, 17) and this approach will, therefore, be general, not requiring individual targeting for individual classes of tumors. The signal to background ratio exceeds four even in this preliminary preclinical study. Further adjustments of dye loading on the polymeric agents and dose values for injection would likely achieve a much higher S/B ratio. For example, it is a simple matter to increase dye loading to as high as eight to ten per polymer without incurring significant quenching losses or alterations in tumor permeation characteristics. This would imply an increase of S/B by a factor 8-10 over the results of Figure 6 , for the same polymer dose and time delay as in those experiments, assuming the signal dependence with dye dose remains linear. Background autofluoresence could also be diminished by the use of NIR dyes with longer emission wavelengths than for Cy5, which emits at 665 nm. It is also evident that the washout rate from the tumor boundaries is slow and at 24 hours there is only a small loss of signal compared to 12 hours. The washout rate and the tumor uptake rate are dependent on polymer length. Shorter polymers will enter more quickly and will also washout faster (data not shown). Therefore, there may be an optimum length depending on what is required for surgery and for pre-surgery planning.
Targeting of integrin α v β 3 receptors may be another general route to delineate tumor boundaries (5, 18). However, the increased expression of these integrins in angiogenic vessels may not be high enough in all tumors to give sufficient discrimination. In one preclinical model, glioma U87MG, the highest S/B values reported for an RGD-Cy5.5 agent was only three at two hours and faded to two by 24 hours (5). Furthermore, from the dual agent application view point, the MRI signals from targeted liposomes to the integrins were somewhat weak as well, giving only ~15% enhancement (18), again suggesting expression of these integrins in angiogenic vessels is not hugely up-regulated.
In a preclinical study, targeting of glioma tumors with Cy-5.5 labeled iron oxide agents gave impressive intraoperative tumor boundary localization by fluorescence and gave presurgery T 2 weighted MRI localization of the tumor (8). As in this case, tumor cells were not labeled directly; rather the iron oxide particles were sequestered in adjoining microglia cells and infiltrating macrophages, which extended a small distance beyond the tumor cell boundary. It is an alternative strategy relying on a different process of tumor delineation and a negative MRI signal enhancement. Both this and the present imaging strategy may each have their virtues depending on what tumors and surgical procedures are to be used.
The dual modality polymeric agent does not directly sequester with tumor cells in this tumor model. The injected agent permeates through the leaky angiogenic vessels, which are recruited to grow in the periphery of tumors and is sequestered in the interstitial space of those regions some 24 hours later after intravenous injection. Histological microscopy suggests that these interstitial spaces are at some distance beyond the edge of tumor cell growth, on the order of ~200-300 μm. A detailed study of the distances between tumor cell distributions and fluorescence boundaries is ongoing. In some intraoperative settings, tumor margins of 1 mm or less may be insufficient. In that case, excision could proceed at some predetermined distance beyond the fluorescence boundaries and the experimental margins could be validated by standard histological evaluation.
The effects of high dye loading per polymer, Figures 2 and 3 , were unexpected and are interesting from the point of view of transendothelial transport mechanisms. That such a mechanism is involved rather than alternative pathways of rapid blood clearance is supported by the observation that there is no significant difference in blood circulation levels after 30 minutes between dye-free polymers, low dye-load polymers, and high dye-load polymers (by MRI signal levels for mid-brain vein and for kidney medulla, data not shown). If blood clearance rate is not the driving factor for the observed collapse of MRI signal enhancement, then what remains is tumor permeation rate decrease, tumor washout acceleration, or sequestration into an intra-cellular compartment with restricted water exchange. The last process is the simplest to address experimentally: If there is little tumor fluorescence signal for the high dye loaded polymer at the same doses as shown for Figure 6 , then the sequestration and restricted water exchange mechanism that could explain the low MR signals can be ruled out. This experiment is underway.
What of the first and second mechanism? It is difficult to explain lack of signal at short times post injection by a change in the tumor washout rate. Given an unaltered entry rate into the tumor extravascular space, there should be detectable accumulation of agent there that would peak at some time post injection given by an equilibration between entry rate and exit rate -see, for example, the standard two compartment kinetic models for low molecular weight agents (19, 20) . The lack of any such agent accumulation in the extravascular space by DCE-MRI, dynamic data for high dye loading in Figure  3 for example, points directly at the entry rate alteration as the source of the lack of signal at short times as well as long. Again, dynamic fluorescence data for various dye-loading conditions would directly clarify the interpretation and rule out effects that may apply to MRI signal development alone.
Aside from these mechanistic questions, further evolution of this macromolecular strategy for intraoperative tumor margin delineation may be through the use of polymers with less potential for toxicity in human use. One such change would be to replace Gd III with Fe III in the labeling of the DTPA groups of the polymer. Sufficient MR signal could still be obtained for the tumor localization aspect of preoperative procedures while greatly reducing the toxic potential of the agent. If the application is to be for intraoperative surgery procedures alone, then it may be possible to eliminate the labeling of the polymers with paramagnetic ions entirely.
